Cytokinetics, Incorporated (CYTK) stock analysis

In our weekly check, Cytokinetics, Incorporated is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 8 pass, warnings: 2, red flags: 12.

About Cytokinetics, Incorporated

Cytokinetics, Incorporated is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as CYTK.

What our checks show for CYTK

Red flags

Warning signs

Strengths

Similar companies

ABVX · RYTM · AXSM · TWST · PTGX · ORKA

Questions

What grade does Cytokinetics, Incorporated (CYTK) have?

In our weekly check, Cytokinetics, Incorporated is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 8 pass, warnings: 2, red flags: 12. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of CYTK stock?

This week's biggest flags for Cytokinetics, Incorporated: High debt, Weak interest cover, Margins falling. In total 14 of 22 checks show a warning or a red flag.

What does Cytokinetics, Incorporated do?

Cytokinetics, Incorporated is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as CYTK.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis